Is skin rash a common symptom of Prostate Cancer?

Skin rash is not a typical symptom of prostate cancer itself, but rashes can occur as side effects of several prostate cancer treatments, especially certain hormone therapies and immunotherapies. ^[1] Rashes and other skin changes can also appear during radiation therapy to any body area being treated. ^[2]

---

How rashes can arise

• Hormone therapies (androgen receptor inhibitors): Newer anti-androgen drugs, such as apalutamide, are known to cause skin reactions ranging from mild red, itchy rashes to more severe eruptions. Rash can appear within the first weeks to months of treatment and may require dose changes or stopping the drug in severe cases. [PM14] In rare situations, severe reactions like Stevens–Johnson syndrome/toxic epidermal necrolysis have been reported with apalutamide. [PM16]

• Immunotherapy: Immune‑based treatments used in advanced prostate cancer can trigger itchy skin and rashes because they activate the immune system, which can sometimes inflame the skin and other organs. ^[1] Dryness, itch, and rash are recognized immunotherapy skin side effects that should be reported early. ^[3]

• Radiation therapy: Skin in the treated area can become dry, itchy, flaky, or develop a rash, and previously sun‑exposed or previously irradiated skin may react more strongly. ^[2] A rash can occasionally signal infection, so it’s important to alert your care team. ^[2]

---

Is skin rash a sign the cancer has spread?

Cutaneous (skin) metastases from prostate cancer are very rare, and most rashes in people with prostate cancer are due to treatment rather than the cancer spreading to the skin. If a new, firm skin nodule appears (especially near the lower abdomen, groin, or surgical scars), or a persistent, unusual lesion develops, your team may consider biopsy to rule out other causes. While metastatic prostate cancer often involves bones and sometimes other organs, typical treatment plans focus on systemic therapies and targeted radiation rather than skin disease. ^{[4] [5]}

---

What to watch for

• Mild reactions: Red, bumpy, dry, or itchy rash without blisters or pain can be managed conservatively. ^[2]
• Moderate to severe reactions: Rapid spreading rash, blistering, skin peeling, mouth/eye involvement, fever, or feeling unwell needs urgent medical review, as these can represent severe drug reactions. [PM16]
• During immunotherapy: Any new rash or itch should be reported promptly, because early treatment helps prevent complications. ^[3]
• During radiation: New or worsening rash or open, peeling skin in the treated area should be discussed with your team, to prevent infection and adjust skin care. ^[2]

---

Practical management tips

• Gentle skin care: Use fragrance‑free moisturizers (e.g., sorbolene, aqueous cream, Eucerin, CeraVe, Aquaphor) once or more daily to reduce dryness and itch. ^{[2] [3]}
• Avoid irritants: Choose mild soaps, lukewarm showers, and soft clothing; avoid scratching to prevent skin breakdown. ^[2]
• Topical treatments: Your clinician may prescribe low‑ to medium‑potency steroid creams for inflammatory rashes from immunotherapy or hormone therapy. ^[3]
• Sun protection: Wear sun‑protective clothing and high‑SPF sunscreen for sensitive, treated skin. ^[2]
• Medication adjustments: For drug‑induced rashes (e.g., apalutamide), clinicians may reduce the dose, pause, or stop the medication, and use antihistamines or systemic steroids if needed. [PM14]
• Emergency care: Blistering, skin peeling, widespread rash, or mucosal involvement requires urgent evaluation; severe cases may need hospitalization and treatments like intravenous steroids or immunoglobulin. [PM16]

---

When to call your care team

• Rash that is rapidly spreading, painful, or blistering. [PM16]
• Rash with fever or feeling generally unwell. [PM16]
• Any rash appearing during immunotherapy, even if mild, to guide early treatment. ^[3]
• New rash in a radiation field, especially if the skin opens or peels. ^[2]

---

Key takeaways

• Skin rash is uncommon from the cancer itself, but is a recognized side effect of several prostate cancer treatments, including androgen receptor inhibitors, immunotherapy, and radiation. ^[1] [PM14] ^{[3] [2]}
• Early reporting and gentle skin care help keep mild rashes under control and prevent complications. ^{[3] [2]}
• Severe or unusual rashes need urgent medical review, as rare but serious reactions can occur with some therapies. [PM16]

---

궁금한 점 있으면 언제든 퍼슬리에 물어보세요